ACR Convergence 2025| Video: Rheuminations on Milestones & Ageism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: hospital

FDA Issues Updated Prescribing Information for Opioids & Over-the-Counter Naloxone

Michele B. Kaufman, PharmD, BCGP  |  June 13, 2023

New prescribing guidance has been issued by the FDA for immediate-release and extended-release/long-acting opioids for pain management. The agency also announced multiple label updates, which include changes to the Boxed Warnings.

Filed under:AnalgesicsDrug Updates Tagged with:FDAopioidPain ManagementPain Syndrome FocusRheumprescribingPrescribing RulesU.S. Food and Drug Administration (FDA)

Summer 2023’s Awards, Appointments & Announcements in Rheumatology

Gretchen Henkel  |  June 10, 2023

Arthritis Foundation Establishes Dr. Herbert S.B. Baraf Award for Excellence in Arthritis Care In October 2022 at its annual Commitment to a Cure Gala, the metropolitan Washington, D.C., chapter of the Arthritis Foundation presented its medical honoree, Herbert S.B. Baraf, MD, FACP, MACR, with the inaugural eponymous Dr. Herbert S.B. Baraf Award for Excellence in…

Filed under:AwardsProfessional Topics Tagged with:Dr. Herbert S. B. BarafEthan CraigMathieu Nelessen

Rheum After 5: Dr. Nigil Haroon, Photographer

Carol Patton  |  June 10, 2023

Roughly six years ago, Nigil Haroon, MD, PhD, MBA, division head of rheumatology at the University Health Network, Toronto, traveled almost 9,000 miles from his home to Papua, New Guinea. His plan was to photograph the Raggiana bird-of-paradise, which can only be found in the tropical forests of eastern New Guinea. He spent about two…

Filed under:ProfilesRheum After 5 Tagged with:Dr. Nigil Haroon

Case Report: A Patient Presents with Digital Ischemia & Gangrene

Nedal Darwish, MD, Mohamed Manaa, MD, Griffin Reyes, MD, & James G. Freeman, MD  |  June 10, 2023

Defined by the presence of antiphospholipid antibodies (aPL) in individuals with clinical evidence of thrombosis or pregnancy morbidity, antiphospholipid syndrome (APS) is a systemic autoimmune thrombophilia. Clinical thrombosis, which should be confirmed by objective validated criteria (e.g., imaging studies or histopathology), can occur in the arterial, venous or small vessel vasculature and is not limited…

Filed under:ConditionsHome SliderOther Rheumatic Conditions Tagged with:Antiphospholipid Antibody Syndrome (APS)arthralgiascase reportdigital ischemiagangrene

How to Discuss Anti-Inflammatory Diets & Supplements with Your Patients

Emily Molina, MD  |  June 9, 2023

My patients ask me almost daily what kind of diet they should be on, or if there are certain supplements they should try. And a growing amount of evidence shows lifestyle and dietary factors may contribute to disease risk and outcomes in rheumatic disease. Thus, rheumatologists and rheumatology professionals are being called upon by patients…

Filed under:ConditionsHome SliderPatient Perspective Tagged with:Dietdietary supplementpatient communication

Don’t Let a Good Mentor Get Away

Bharat Kumar, MD, MME, FACP, FAAAAI, RhMSUS  |  June 9, 2023

“When you get a good mentor, don’t let ’em be the one that got away.” Richard Brasington Jr., MD, FACP, MACR, told me this about a decade ago when I was a rheumatology fellowship applicant and first met him. It was clear the statement was influenced by his love of fishing. Dr. Brasington’s office was…

Filed under:Career DevelopmentOpinionProfessional TopicsRheuminationsSpeak Out Rheum Tagged with:Dr. Hanna W. MawadDr. Mark F. GourleyDr. Richard Brasington Jr.Dr. Robert Wilkins LightfootMentorMentoringMentorship

Welcome Home: ACR & ARP Join Forces to Introduce a New Membership Model

Elizabeth Hofheinz, MPH, MEd  |  June 5, 2023

A pilot membership model is empowering members to come home to the ACR/ARP, with a streamlined website, as well as simplified, robust membership options.

Filed under:American College of RheumatologyFrom the CollegeProfessional Topics Tagged with:ACR/ARP membershipmembership model

Thick Skin & Solid Research: Necessary Ingredients for Publishing Success

Vanessa Caceres  |  June 1, 2023

Scientific publishing requires a commitment to clear writing, concise narratives and a willingness to accept feedback. Daniel Solomon, MD, editor-in-chief of Arthritis & Rheumatology, provides insights into his experiences.

Filed under:Career DevelopmentProfessional TopicsResearch Rheum Tagged with:ACR on AirACR on Air podcastArthritis & RheumatologyCareer tipsDr. Daniel Solomonpublishing

Methotrexate Shortage: Why It’s Happening & Potential Solutions

Michele B. Kaufman, PharmD, BCGP  |  May 31, 2023

In recent months, many rheumatologists and rheumatology professionals have noted issues related to obtaining supplies of injectable and oral methotrexate for their patients with rheumatoid arthritis (RA). A conventional synthetic disease-modifying anti-rheumatic drug (csDMARD), methotrexate is available as both oral tablets and as a subcutaneous injection for the treatment of RA and other autoimmune diseases.1…

Filed under:Drug Updates Tagged with:Drug shortagedrug treatmentMethotrexatepatient careRheumatoid Arthritis (RA)

Adobe Stock / ART STOCK CREATIVE

Large Language Models in Medicine: The potential to reduce workloads, leverage the EMR for better communication & more

Jacqueline Jansz, MD, & Peter T. Sadelski, JD  |  May 17, 2023

Large language models are a type of AI that allows users to generate new content, drawing from a huge dataset to learn how to mimic “natural language” with many possible beneficial applications for this technology in medicine.

Filed under:AppsHome SliderPractice SupportTechnology Tagged with:AIartificial intelligencelarge language model

  • « Previous Page
  • 1
  • …
  • 35
  • 36
  • 37
  • 38
  • 39
  • …
  • 327
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences